col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: The Japanese Pharmacological Society
  original article Journal Date Title Authors All Authors
1 [GO] Folia Pharmacologica Japonica 2021―Apr―30 Therapeutic potential of nanocurcumin in COVID-19 Koji Teshima
2 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Construction of the multi-layer omics data generation / analysis platform that contributes to the precision medicine of COVID-19 Yumiko Imai
3 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Treatment of COVID-19 Kazuhiro Yatera
4 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Remdesivir for COVID-19 Yasuhisa Fujita
5 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 COVID-19 Drug Candidate Pipeline, An Overview Hiroyuki Sugiyama
6 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19 mouse model Tomokazu Yamaguchi, Takafumi Minato, Midori Hoshizaki, Masamitsu Asaka, Satoru Nirasawa, Mayumi Niiyama, et al. (+10)
7 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Nationwide Emergency Survey Results on the Response to COVID-19 Pandemic and Its Effect on Pharmacological Education Conducted in the Department of Pharmacology in Universities and Colleges Jointly by the Physiology Society of Japan and the Japanese Pharmacological Society. Masaki Mogi, Tomoyuki Furuyashiki, Kazuhiro Takuma, Ken-ichi Otsuguro, Tomoyuki Tanaka, Masabumi Minami
8 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Eco-pharma research aimed at developing COVID-19 therapeutic agent Kato Yuri, Motohiro Nishida
9 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Drug repositioning to combat COVID-19 using artificial intelligence system Norihisa Shindo, Hiroyoshi Toyoshiba
10 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Drug Screening for COVID-19 using Supercomputer "Fugaku" Yasushi Okuno
11 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Contribution to Development of Remedies for COVID-19: Focusing on Eritoran Kappei Tsukahara
12 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2021―Mar―20 Investigation of genetic variants in SARS-CoV-2-interacting molecules of ACE2, TMPRSS2 and TLR3/7/8 across populations Lee Ji-Won, In-Hee Lee, Sek Won Kong, Tadahiro Iimura
13 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2020―Mar―17 Treatment to prevent the development of severe COVID-19 Yumiko Imai
14 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2020―Mar―17 In silico approaches to drug repositioning for COVID-19 at AMED-BINDS Takatsugu Hirokawa, Sekijima Masakazu, Shigenori Tanaka, Haruki Nakamura
15 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2020―Mar―17 Nonstructural proteins of Novel Coronavirus (SARS-CoV-2) Wataru Kamitani
16 [GO] Proceedings for Annual Meeting of The Japanese Pharmacological Society 2020―Mar―17 The initial response of the laboratory diagnosis team to SARS-CoV-2 in Japan and the current situation Makoto Takeda


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.011 sec